Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to $3.1 million.

  • AtriCure's Other Non-Current Assets rose 172.64% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year increase of 172.64%. This contributed to the annual value of $2.9 million for FY2024, which is 3277.78% up from last year.
  • AtriCure's Other Non-Current Assets amounted to $3.1 million in Q3 2025, which was up 172.64% from $2.8 million recorded in Q2 2025.
  • AtriCure's 5-year Other Non-Current Assets high stood at $3.3 million for Q1 2024, and its period low was $474000.0 during Q1 2021.
  • In the last 5 years, AtriCure's Other Non-Current Assets had a median value of $1.6 million in 2023 and averaged $1.9 million.
  • Per our database at Business Quant, AtriCure's Other Non-Current Assets soared by 16441.1% in 2021 and then crashed by 2142.18% in 2022.
  • Quarter analysis of 5 years shows AtriCure's Other Non-Current Assets stood at $955000.0 in 2021, then skyrocketed by 107.85% to $2.0 million in 2022, then rose by 8.82% to $2.2 million in 2023, then skyrocketed by 32.78% to $2.9 million in 2024, then rose by 6.83% to $3.1 million in 2025.
  • Its Other Non-Current Assets stands at $3.1 million for Q3 2025, versus $2.8 million for Q2 2025 and $2.8 million for Q1 2025.